Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

148.68 -0.16 (-0.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
The 5 Most Interesting Analyst Questions From Insulet’s Q1 Earnings Call
Insulet’s first quarter was marked by robust revenue growth, driven by continued adoption of its Omnipod 5 insulin delivery system across both U.S. and inter... 
Via StockStory
Topics Earnings
News headline image
Why Insulet (PODD) Stock Is Trading Up Today
What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 3.4% in the afternoon session after Benchmark initiated coverage o... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Quality Compounders to Research Further
Quality compounders are flywheels. Said differently, they’re businesses that generate heaps of profits and consistently reinvest them to produce even more pr... 
Via StockStory
Insulet Corp (NASDAQ:PODD) Blows Past Q1 Estimates, Raises Full-Year Revenue Guidance ↗
Via Chartmill
INSULET CORP (NASDAQ:PODD): A Textbook GARP Candidate for Affordable Growth Investors ↗
Via Chartmill
Insulet Corp (NASDAQ:PODD): A Prime GARP Investment with Strong Growth and Reasonable Valuation ↗
Via Chartmill
Which S&P500 stocks are moving on Thursday? ↗
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Which S&P500 stocks have an unusual volume on Wednesday? ↗
Via Chartmill
News headline image
Insulet (PODD) Q1 2026 Earnings Transcript ↗
Insulet (PODD) Q1 2026 Earnings Transcript 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
Insulet (NASDAQ:PODD) Reports Upbeat Q1 CY2026, Stock Soars
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 33.9% year on... 
Via StockStory
News headline image
Insulet Reports First Quarter 2026 Results
From Insulet Corporation
Via Business Wire
News headline image
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
From Insulet Corporation
Via Business Wire
News headline image
Earnings To Watch: Insulet (PODD) Reports Q1 Results Tomorrow
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what investors should know. Insulet beat... 
Via StockStory
News headline image
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Insulet to Participate in BofA Securities 2026 Health Care Conference
From Insulet Corporation
Via Business Wire
News headline image
1 Oversold Stock Primed to Rebound and 2 We Ignore
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co... 
Via StockStory
News headline image
2 of Wall Street’s Favorite Stocks for Long-Term Investors and 1 We Turn Down
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
Topics Retirement
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
2 High-Flying Stocks to Own for Decades and 1 We Turn Down
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo... 
Via StockStory
Topics Supply Chain
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
Insulet (PODD): 3 Reasons We Love This Stock
What a brutal six months it’s been for Insulet. The stock has dropped 33.8% and now trades at $204.57, rattling many shareholders. This may have investors wo... 
Via StockStory
News headline image
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
Shares of Eli Lilly and Company (NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require... 
Via MarketMinute
Topics Economy
News headline image
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
From Insulet Corporation
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.